Insider Transactions in Q2 2019 at Accenture PLC (ACN)
Insider Transaction List (Q2 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 22
2019
|
Chad T Jerdee General Counsel and CCO |
SELL
Open market or private sale
|
Direct |
2,441
-15.43%
|
$432,057
$177.77 P/Share
|
|
Apr 22
2019
|
Daniel T London Group Chief Exec - Health & PS |
SELL
Open market or private sale
|
Direct |
2,042
-7.11%
|
$361,434
$177.79 P/Share
|
|
Apr 22
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
SELL
Open market or private sale
|
Direct |
18,000
-13.73%
|
$3,186,000
$177.78 P/Share
|
|
Apr 22
2019
|
Julie Spellman Sweet Chair and CEO |
SELL
Open market or private sale
|
Direct |
2,568
-13.46%
|
$454,536
$177.76 P/Share
|
|
Apr 22
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
SELL
Open market or private sale
|
Direct |
8,000
-6.41%
|
$1,416,000
$177.78 P/Share
|
|
Apr 05
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
28
+0.07%
|
$4,956
$177.73 P/Share
|
|
Apr 05
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
115
+0.57%
|
$20,355
$177.73 P/Share
|
|
Apr 05
2019
|
Chad T Jerdee General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
91
+0.57%
|
$16,107
$177.73 P/Share
|
|
Apr 05
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
147
+0.51%
|
$26,019
$177.73 P/Share
|
|
Apr 05
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct |
138
+0.11%
|
$24,426
$177.73 P/Share
|
|
Apr 05
2019
|
Kathleen R Mc Clure Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
91
+0.43%
|
$16,107
$177.73 P/Share
|
|
Apr 05
2019
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
137
+0.41%
|
$24,249
$177.73 P/Share
|
|
Apr 05
2019
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
80
+0.42%
|
$14,160
$177.73 P/Share
|
|
Apr 05
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
BUY
Grant, award, or other acquisition
|
Direct |
160
+0.13%
|
$28,320
$177.73 P/Share
|
|
Apr 01
2019
|
Johan Deblaere Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,000
-1.98%
|
$525,000
$175.83 P/Share
|
|
Apr 01
2019
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Open market or private sale
|
Direct |
2,343
-3.3%
|
$412,368
$176.06 P/Share
|
|
Apr 01
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
SELL
Open market or private sale
|
Direct |
4,000
-1.56%
|
$700,000
$175.99 P/Share
|
|
Apr 01
2019
|
David Rowland Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
6,182
-16.23%
|
$1,081,850
$175.65 P/Share
|